A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer
2004 · New England Journal of Medicine · 6,253 citations
https://doi.org/10.1056/nejmoa041588
J
John Bryant
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
384
Papers
41.5K
Citations
58
h-index
140
i10-index
John Bryant is an academic researcher from University of Tennessee Health Science Center. The author has contributed to research in topics: Breast Cancer Treatment Studies & Digital Humanities and Scholarship & Pulsars and Gravitational Waves Research. The author has an h-index of 58, co-authored 327 publications.
ORCID: 0000-0002-7243-3230Papers by this author
worksTwenty-Year Follow-up of a Randomized Trial Comparing Total Mastectomy, Lumpectomy, and Lumpectomy plus Irradiation for the Treatment of Invasive Breast Cancer
2002 · New England Journal of Medicine · 6,131 citations
https://doi.org/10.1056/nejmoa022152
Trastuzumab plus Adjuvant Chemotherapy for Operable HER2-Positive Breast Cancer
2005 · New England Journal of Medicine · 5,324 citations
https://doi.org/10.1056/nejmoa052122
Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials
2017 · The Lancet Oncology · 1,113 citations
https://doi.org/10.1016/s1470-2045(17)30777-5
erbB-2 and Response to Doxorubicin in Patients With Axillary Lymph Node-Positive, Hormone Receptor- Negative Breast Cancer
1998 · JNCI Journal of the National Cancer Institute · 653 citations
https://doi.org/10.1093/jnci/90.18.1361
Pathobiology of preoperative chemotherapy
2002 · Cancer · 410 citations
https://doi.org/10.1002/cncr.10741
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat